Bronchiolitis pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Bot: Removing from Primary care)
 
(29 intermediate revisions by 7 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Bronchiolitis}}
{{Bronchiolitis}}
{{CMG}}; {{AE}} {{Alonso}}
{{CMG}}; {{AE}} {{Alonso}}, {{AEL}}  


==Overview==
==Overview==


Bronchiolitis is transmitted via air droplets. It is caused by [[respiratory syncytial virus]] ([[Human respiratory syncytial virus|RSV]]), which [[Infect|infects]] the [[nasopharyngeal]] [[mucosa]]. After the [[infection]], the [[virus]] spreads to the [[Lower respiratory tract|lower airway tracts]] until it reaches the [[bronchioles]], where [[viral replication]] takes place. The viral [[infection]] induces [[inflammation]], which leads to [[edema]] and [[necrosis]] of the [[bronchioles|bronchiolar]] [[epithelium]]. [[Cough reflex]] occurs due to exposure of the subepithelial [[tissue]] and [[nerve fibers]]. [[Vascular]] [[permeability]] increases, leading to [[edema]] and [[swelling]]. [[Histopathological|Histopathologically]], [[bronchiolitis obliterans]] shows [[intraluminal]] [[polyps]], [[inflammatory]] [[Infiltration (medical)|infiltration]], and [[macrophages]]. Constrictive bronchiolitis shows thickening of the [[airways]] and [[Lumen|interluminal]] narrowing.
==Pathophysiology==
===Transmission===
*[[Bronchiolitis]] is not transmissible between individuals. However, when [[bronchiolitis]] is caused by [[Respiratory syncytial virus|respiratory syncytial virus (RSV)]], it may be transmitted via air droplets.
*Air droplets containing [[Respiratory syncytial virus|respiratory syncytial virus (RSV)]] lead to [[infection]] of the [[Nasopharyngeal|nasopharyngeal mucosa]] and subsequent [[bronchiolitis]].
===Pathogenesis===
[[Bronchiolitis]] is caused by [[viral replication]] and [[inflammation]] as follows:<ref name="pmid23102068">{{cite journal| author=Garibaldi BT, Illei P, Danoff SK| title=Bronchiolitis. | journal=Immunol Allergy Clin North Am | year= 2012 | volume= 32 | issue= 4 | pages= 601-19 | pmid=23102068 | doi=10.1016/j.iac.2012.08.002 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23102068  }} </ref>
*Starting from the [[nasopharyngeal]] [[mucosa]], [[Human respiratory syncytial virus|respiratory syncytial virus (RSV)]] spreads to the [[Lower respiratory tract|lower respiratory tracts]]. After reaching the [[bronchioles]], [[viral replication]] takes place.
*The [[viral infection|respiratory syncytial virus (RSV)]] [[viral infection|infection]] induces an [[inflammatory]] response. This leads to [[Infiltration (medical)|infiltration]] of [[Inflamation#Celular component|inflammatory cells]] ([[RSV]]-specific [[lymphocytes]]), [[edema]], and [[necrosis]] of the [[epithelium]] in the [[bronchioles]]. The [[epithelium]] is then sloughed into the [[Luminal|lumina]], causing [[proliferation]] of [[cuboidal]] [[epithelial cells]] without [[cilia]].<ref name="Mandell">{{Cite book  | last1 = Mandell | first1 = Gerald L. | last2 = Bennett | first2 = John E. (John Eugene) | last3 = Dolin | first3 = Raphael. | title = Mandell, Douglas, and Bennett's principles and practice of infectious disease | date = 2010 | publisher = Churchill Livingstone/Elsevier | location = Philadelphia, PA | isbn = | pages = }}</ref>
*[[Virus|Respiratory syncytial virus (RSV)]] causes [[lysis]] of the [[epithelial]] [[tissue]], which leads to the exposure of the subepithelial [[tissue]] and [[nerve fibers]], inducing a [[cough reflex]].
*The [[vascular]] [[permeability]] increases, which results in [[edema]] and [[swelling]].
*This [[inflammatory]] process leads to complete or partial [[obstruction]] due to reduction in [[Bronchiolar epithelium|bronchiolar]] lumina. Accumulation of [[Necrosis|necrotic tissue]] produces a [[valve]] mechanism, leading to hyperinflation of the [[lungs]]. 
*By this mechanism, air flow may increase into the [[lungs]] by increased negative pressure during [[inspiration]] but is unable to flow out of the lung, as the airway's diameter is smaller during [[expiration]].<ref name="Mandell">{{Cite book  | last1 = Mandell | first1 = Gerald L. | last2 = Bennett | first2 = John E. (John Eugene) | last3 = Dolin | first3 = Raphael. | title = Mandell, Douglas, and Bennett's principles and practice of infectious disease | date = 2010 | publisher = Churchill Livingstone/Elsevier | location = Philadelphia, PA | isbn = | pages = }}</ref> Obstructed areas may evolve into areas of [[atelectasis]].
*In children, Kohn channels are not well developed, so [[atelectasis]] and hyperinflation may be more severe.
== Associated conditions ==
* There are no associated conditions with bronchiolitis.


==Pathophysiology==
== Gross pathology ==
The [[viral infection]] induces an [[inflammatory]] response which leads to infiltration of [[Inflamation#Celular component|inflammatory cells]] (RSV-specific lymphocytes), [[edema]] and [[necrosis]] of the [[epithelium]] in the [[bronchioles]] which is then sloughed into the lumina causing proliferation of cuboidal epithelial cells without cilia.<ref name="Mandell">{{Cite book  | last1 = Mandell | first1 = Gerald L. | last2 = Bennett | first2 = John E. (John Eugene) | last3 = Dolin | first3 = Raphael. | title = Mandell, Douglas, and Bennett's principles and practice of infectious disease | date = 2010 | publisher = Churchill Livingstone/Elsevier | location = Philadelphia, PA | isbn = | pages = }}</ref><ref name="pmid19209271">{{cite journal| author=Wright M, Mullett CJ, Piedimonte G| title=Pharmacological management of acute bronchiolitis. | journal=Ther Clin Risk Manag | year= 2008 | volume= 4 | issue= 5 | pages= 895-903 | pmid=19209271 | doi= | pmc=PMC2621418 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19209271 }} </ref> This phenomena leads to complete or partial obstruction due to reduction of the bronchiolar lumina and [[Necrosis|necrotic tissue]] accumulation producing a valve mechanism, leading to hyperinflation.  By this mechanism, air can flow into the [[lungs]] by increased negative pressure during [[inspiration]] but is unable to flow out of the lung as the airway's diameter is smaller during [[expiration]].<ref name="Mandell">{{Cite book  | last1 = Mandell | first1 = Gerald L. | last2 = Bennett | first2 = John E. (John Eugene) | last3 = Dolin | first3 = Raphael. | title = Mandell, Douglas, and Bennett's principles and practice of infectious disease | date = 2010 | publisher = Churchill Livingstone/Elsevier | location = Philadelphia, PA | isbn = | pages = }}</ref>  Obstructed areas can evolve to [[atelectasis]]. In children, Kohn channels are not well developed, therefore [[atelectasis]] and hyperinflation can be greater.
* There are no specific findings in the gross pathology of bronchiolitis.
 
==Microscopic pathology==
[[Bronchiolitis]] shows [[histopathological]] findings which vary according to different types of [[bronchiolitis]].<ref name="pmid16088569">{{cite journal| author=Couture C, Colby TV| title=Histopathology of bronchiolar disorders. | journal=Semin Respir Crit Care Med | year= 2003 | volume= 24 | issue= 5 | pages= 489-98 | pmid=16088569 | doi=10.1055/s-2004-815600 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16088569 }} </ref>
*[[Bronchiolitis obliterans]]:
**Intraluminal [[polyps]] (protrusions inside the [[bronchioles]] with [[fibroblastic]] [[proliferation]])
**[[Inflammatory]] [[Infiltration (medical)|infiltration]]
**[[Pneumocytes|Type two pneumocytes]] lining the [[alveoli]]
**[[Macrophages]]
 
*Constrictive bronchiolitis:
**[[Scar|Scars]] leading to interluminal narrowing and [[obstruction]]
**Thickening of the [[airways]] due to [[submucosal]] [[collagen]] and [[fibrosis]]


Bronchiolitis is usually a self-limited infection which should be eliminated during the next 2 weeks after infection in immunocompetent patients. However, dissemination of the [[Respiratory syncytial virus|virus]] in [[Immunodeficiency overview|immunocompromised]] patients could remain for several months after initial infection.<ref name="pmid19209271">{{cite journal| author=Wright M, Mullett CJ, Piedimonte G| title=Pharmacological management of acute bronchiolitis. | journal=Ther Clin Risk Manag | year= 2008 | volume= 4 | issue= 5 | pages= 895-903 | pmid=19209271 | doi= | pmc=PMC2621418 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19209271  }} </ref>
*[[Proliferative bronchiolitis]]:
**[[Histopathology]] shows Masson bodies ([[Fibrosis|fibrotic]] buds extending into [[alveoli]])


Some children present recurrent episodes of [[wheezing]] after the initial [[RSV]] infection which has been associated with the type of [[inflamatory response]] the patients presents during the initial disease. Animal and, in less dimension, human models have shown that [[inflamation]] mediated by Th2 cellular response is associated with increased production of [[IgE]] and proimmflamatory mediators present in [[asthma]] patients.<ref name="Mandell">{{Cite book  | last1 = Mandell | first1 = Gerald L. | last2 = Bennett | first2 = John E. (John Eugene) | last3 = Dolin | first3 = Raphael. | title = Mandell, Douglas, and Bennett's principles and practice of infectious disease | date = 2010 | publisher = Churchill Livingstone/Elsevier | location = Philadelphia, PA | isbn = | pages = }}</ref>
[[Image:Acute bronchiolitis (8519105494).jpg|500px|thumb|center|Acute inflammatory exudate causing occlusion of the lumen of the bronchiole. Source: Yale Rosen - Acute bronchiolitis, CC BY-SA 2.0, https://commons.wikimedia.org/w/index.php?curid=31127127 ]]


==References==
==References==
Line 17: Line 48:
{{Reflist|2}}
{{Reflist|2}}


{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
[[Category:Disease]]
[[Category:Up-To-Date]]
[[Category:Pulmonology]]
[[Category:Pediatrics]]
[[Category:Pediatrics]]
[[Category:Pulmonology]]
[[Category:primary care]]
[[Category:Emergency medicine]]
[[Category:Emergency medicine]]
 
[[Category:Infectious disease]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Latest revision as of 20:44, 29 July 2020

Bronchiolitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Bronchiolitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Severity Score

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Bronchiolitis pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Bronchiolitis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Bronchiolitis pathophysiology

CDC on Bronchiolitis pathophysiology

Bronchiolitis pathophysiology in the news

Blogs on Bronchiolitis pathophysiology

Directions to Hospitals Treating Bronchiolitis

Risk calculators and risk factors for Bronchiolitis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alonso Alvarado, M.D. [2], Ahmed Elsaiey, MBBCH [3]

Overview

Bronchiolitis is transmitted via air droplets. It is caused by respiratory syncytial virus (RSV), which infects the nasopharyngeal mucosa. After the infection, the virus spreads to the lower airway tracts until it reaches the bronchioles, where viral replication takes place. The viral infection induces inflammation, which leads to edema and necrosis of the bronchiolar epithelium. Cough reflex occurs due to exposure of the subepithelial tissue and nerve fibers. Vascular permeability increases, leading to edema and swelling. Histopathologically, bronchiolitis obliterans shows intraluminal polyps, inflammatory infiltration, and macrophages. Constrictive bronchiolitis shows thickening of the airways and interluminal narrowing.

Pathophysiology

Transmission

Pathogenesis

Bronchiolitis is caused by viral replication and inflammation as follows:[1]

Associated conditions

  • There are no associated conditions with bronchiolitis.

Gross pathology

  • There are no specific findings in the gross pathology of bronchiolitis.

Microscopic pathology

Bronchiolitis shows histopathological findings which vary according to different types of bronchiolitis.[3]

Acute inflammatory exudate causing occlusion of the lumen of the bronchiole. Source: Yale Rosen - Acute bronchiolitis, CC BY-SA 2.0, https://commons.wikimedia.org/w/index.php?curid=31127127

References

  1. Garibaldi BT, Illei P, Danoff SK (2012). "Bronchiolitis". Immunol Allergy Clin North Am. 32 (4): 601–19. doi:10.1016/j.iac.2012.08.002. PMID 23102068.
  2. 2.0 2.1 Mandell, Gerald L.; Bennett, John E. (John Eugene); Dolin, Raphael. (2010). Mandell, Douglas, and Bennett's principles and practice of infectious disease. Philadelphia, PA: Churchill Livingstone/Elsevier.
  3. Couture C, Colby TV (2003). "Histopathology of bronchiolar disorders". Semin Respir Crit Care Med. 24 (5): 489–98. doi:10.1055/s-2004-815600. PMID 16088569.


Template:WikiDoc Sources